Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Nov, 22 2025
Dec, 27 2025
May, 24 2025
Jan, 3 2026
Nov, 9 2023